Hjem › Fokal segmental glomerulosklerose › Texas
Fokal segmental glomerulosklerose kliniske forsøg i Texas
5 studier for Fokal segmental glomerulosklerose søger deltagere på steder i Texas.
Byer i Texas
Officiel studietekst (engelsk)
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #5, Arlington
- Investigator Site #21, Dallas
- Investigator Site #9, Dallas
- og 1 flere
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07268638A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- Texas Tech University Health Sciences Center-Amarillo-63885, Amarillo
- The Healing Kidneys Institute, Conroe
- Advanced Dallas Hospital and Clinics, Dallas
- og 4 flere
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07220083A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Renal Disease Research Institute - Dallas - Live Oak Street- Site Number : 8400024, Dallas
- El Paso Kidney Specialists- Site Number : 8400005, El Paso
- Prolato Clinical Research Center- Site Number : 8400016, Houston
RekruttererFase 2
Alder 16 til 75 · Alle køn · Opdateret 23. sep. 2026 · NCT06500702Nephrotic Syndrome Study Network
- University of Texas-Southwestern, Dallas
- Texas Children's Hospital - Baylor College of Medicine, Houston
RekruttererObservationsstudie
Op til 80 år · Alle køn · Opdateret 10. jun. 2026 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Texas Children's Hospital, Houston
RekruttererFase 2
Alder 1 til 17 · Alle køn · Opdateret 12. maj 2026 · NCT05003986Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.